Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;

Recommendations of the Spanish Working Group on Crohn¿s disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa ¿ GETECCU) on dysplasia screening in inflammatory bowel disease patients Beatriz Sicilia; Raquel Vicente; Lara Arias; Ana Echarri; Yamile Zabana; Miriam Mañosa; Belén Beltrán; Manuel Barreiro-de Acosta;

Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study Pablo Andres Olivera; Domingo Balderramo; Juan Sebastian Lasa; Ignacio Zubiaurre; Gustavo Correa; Pablo Lubrano; Orlando Ruffinengo; Martin Yantorno; Astrid Rausch; Gisela Piñero; Andrea Bolomo; Carla Amigo; Jazmin El-Hakeh; Daiana Beatriz Leonardi; Laura Brion; Alicia Sambuelli;